Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: Possible impact in clinical decision-making?

Autor(es)

Ciolac, Emmanuel Gomes ^[1] ; Bocchi, Edimar Alcides ^[2] ; Fernandes da Silva, Miguel Morita ^[2] ; Tavares, Aline Cristina ^[2] ; Teixeira-Neto, Iram Soares ^[2] ; Guimaraes, Guilherme Veiga ^[2]

Afiliação do(s) autor(es)

^[1] Sao Paulo State Univ, UNESP, Sch Sci, Exercise & Chron Dis Res Lab, Phys Educ Dept, Bauru - Brazil

^[2] Univ Sao Paulo, Hosp Clin, Fac Med, Heart Inst InCor, Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: CARDIOLOGY JOURNAL; v. 20, n. 6, p. 655-661, 2013.
• Citações Web of Science: 4

Resumo

Background: Heart failure (HF) is associated with impaired maximal aerobic capacity as indicated by decreases in peak oxygen uptake (peak VO2). Considering that aging by itself has a negative effect on this variable, the evaluation of maximum capacity is often questioned because current predicted peak VO2 is based on subjects without heart disease or beta-blocker therapy. In contrast, if decline in predicted and attained peak VO2 were age-related, proportionally, loss of aerobic function (predicted peak VO2, %) would remain stable over time in these patients. The purpose of this investigation is to assess the effects of age on peak VO2 in HF patients taking beta-blockers. Methods: We retrospectively evaluated 483 (132 female) patients (aged 20-88 years, LVEF 31 +/- 11%) with non-ischemic (n = 362), ischemic (n = 74) and Chagas-related HF (n = 47) who had been submitted to an incremental cardiopulmonary exercise testing on a motorized treadmill. Linear regression was used to develop the equation to predict peak VO2, based on age. Results: Peak VO2 decreased 0.9 mL/min/kg per age-decade, maximum HR also decreased with aging and VE/VCO2 slope was similar among all decades. The predicted new beta-blocker equation to peak VO2bb was 20.934 - 0.092 x age. Conclusions: Clinical interpretation of aerobic capacity impairment is influenced by aging in HF patients. This evidence must be considered when using peak VO2 for prognostic stratification and clinical decision-making in patients with HF under beta-blocker therapy. (AU)

• Processo FAPESP: 12/02409-0 - Efeitos da atividade física em piscina aquecida versus atividade física em solo na densidade mineral óssea, capacidade física e composição corporal em transplantados cardíacos
• Beneficiário: Emmanuel Gomes Ciolac
• Modalidade de apoio: Auxílio à Pesquisa - Regular